Pilgrim Global Advisors LLC reported SABLE OFFSHORE CORP (SOC) in 9 quarterly 13F filings from 2024 Q1 through 2026 Q1. Peak portfolio weight reached 49.08% in 2025 Q1. The latest visible filing shows SOC at 38.94% of the fund.
This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.
This page is designed to answer the real investor question behind a 13F filing: how meaningful was Pilgrim Global Advisors LLC's position in SABLE OFFSHORE CORP, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.
SOC was reported at 38.94% of portfolio in the most recent visible filing.
Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.
Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.
Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.
As of 2026 Q1 — sorted by position size
These are the practical questions this page is built to answer before you even open the full history table.
Pilgrim Global Advisors LLC reported SOC across 9 quarterly 13F filings, from 2024 Q1 through 2026 Q1.
The largest reported portfolio weight for SOC was 49.08% in 2025 Q1.
The most recent filing on this page is 2026 Q1, when Pilgrim Global Advisors LLC reported 18,206,121 shares, equal to 38.94% of portfolio, with an estimated market value of $300.8M.
The chart compares Pilgrim Global Advisors LLC's quarterly SOC portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.
Based on 13F filing dates vs. subsequent SOC price moves, Pilgrim Global Advisors LLC correctly timed 4 out of 6 reported position changes (67%). The annualised alpha on SOC relative to SPY over the holding period was -7.4%.